Abbott Laboratories (ABT) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025
Abbott Laboratories (NYSE: ABT) heads into Monday’s session with investors weighing a busy set of headlines—ranging from a fresh dividend hike to a high-profile acquisition in cancer diagnostics, plus regulatory attention around certain FreeStyle Libre sensors. ABT closed Friday, Dec.